Plasma cell leukemia
Other Names for this Disease
- Leukemia, plasma cell
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
 Different types of treatments are available for patients with PCL. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. For detailed information on the available treatment options, please visit the following link. http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/Patient/page4Plasma cell leukemia (PCL) is a rare and aggressive form of multiple myeloma that involves high levels of plasma cells circulating in the peripheral blood. The signs and symptoms of PCL include aggressive clinical features, such as extramedullary disease, bone marrow failure, advanced stage disease and expression of distinct immunophenotypic markers.
Last updated: 2/20/2014
- Michaela Liedtke, Bruno C Medeiros. Plasma Cell Leukemia: Concepts and Management. Expert Rev Hematol. 2010; 3(5):543-549. http://www.medscape.com/viewarticle/731900_1. Accessed 2/19/2014.
- The National Cancer Institute provides the most current information on cancer for patients, health professionals, and the general public.
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Plasma cell leukemia. Click on the link to view a sample search on this topic.